Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.33 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.33 |
| ▸ | KLK7 | P49862 | 1/20 | 0.33 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13424415 | 0.84 | PDE4D (0.38) | BCHEACHEPDPK1MTORPDE4D | |
| SCHEMBL13424413 | 0.84 | BCHE (0.36) | BCHEACHEPDPK1MTORMAPT | |
| SCHEMBL12221406 | 0.82 | BCHE (0.49) | BCHEACHEPDPK1MTORMAPT | |
| SCHEMBL2010880 | 0.81 | GJB2 (0.33) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL2010882 | 0.81 | GJB2 (0.33) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL4895151 | 0.80 | CTSL (0.36) | BCHEACHEMAPTCYP2C19PSEN1 | |
| SCHEMBL14107809 | 0.80 | CTSL (0.36) | BCHEACHEMAPTCYP2C19PSEN1 | |
| SCHEMBL2011594 | 0.78 | GJB2 (0.32) | — | |
| SCHEMBL2011597 | 0.78 | GJB2 (0.32) | — | |
| SCHEMBL8461934 | 0.77 | PSEN1 (0.34) | BCHEACHEMAPTCYP2C19PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299223-B2 | Pseudoglycolipid and use thereof | RIKEN (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20100062990-A1 | NOVEL PSEUDOGLYCOLIPID AND USE THEREOF | RIKEN (JP) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062990-A1 | NOVEL PSEUDOGLYCOLIPID AND USE THEREOF | PNLIP, SGMS1, SGPL1 | BCHE 1946/4885ACHE 3384/4885PDPK1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.